Literature DB >> 6402356

[Anti-epileptic agents during pregnancy. A prospective study on the course of pregnancy, malformations and child development].

S Koch, I Göpfert-Geyer, E Jäger-Roman, S Jakob, H Huth, A Hartmann, D Rating, H Helge.   

Abstract

In a prospective controlled study 70 children of females with epilepsy and on anticonvulsant medication during pregnancy were investigated. It was shown that epileptic females had stillbirths more frequently than expected. After delivery particularly children on phenobarbitone are sedated. Due to weak suckling this may lead to inadequate food intake. Withdrawal symptoms manifest in affected children as hyperexcitability lasting for weeks. Children of epileptic women on medication are generally smaller, of lower weight and have smaller heads than children from all control groups. Ingestion of more than one anticonvulsant leads to an even more pronounced reduction of infantile body measurements below the expected mean value. Small malformations are observed more frequently after intrauterine exposition to anticonvulsants than in the control groups. Ingestion of more than one anticonvulsant leads to an increase of the number of small malformations in the child than after single drug therapy. Children of epileptic parents are affected more frequently by large malformations than children of nonepileptic parents.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402356     DOI: 10.1055/s-2008-1069536

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  9 in total

Review 1.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

2.  Persistent behavioral effects following early life exposure to retinoic acid or valproic acid in zebrafish.

Authors:  Jordan M Bailey; Anthony N Oliveri; Nishika Karbhari; Roy A J Brooks; Amberlene J De La Rocha; Sheila Janardhan; Edward D Levin
Journal:  Neurotoxicology       Date:  2015-10-09       Impact factor: 4.294

Review 3.  Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.

Authors:  Jennifer Weston; Rebecca Bromley; Cerian F Jackson; Naghme Adab; Jill Clayton-Smith; Janette Greenhalgh; Juliet Hounsome; Andrew J McKay; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2016-11-07

4.  Increased prevalence of minor anomalies in childhood malignancy.

Authors:  K Méhes; E Signer; H J Plüss; H J Müller; G Stalder
Journal:  Eur J Pediatr       Date:  1985-09       Impact factor: 3.183

Review 5.  Pregnancy, epilepsy, and anticonvulsants.

Authors:  Bernhard J Steinhoff
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

Review 6.  Management of epilepsy during pregnancy.

Authors:  Dina Battino; Torbjörn Tomson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Ethosuximide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentrations in nursed infants and clinical status.

Authors:  W Kuhnz; S Koch; S Jakob; A Hartmann; H Helge; H Nau
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

8.  Malformation rates in children of women with untreated epilepsy: a meta-analysis.

Authors:  Shawn Fried; Eran Kozer; Irena Nulman; Thomas R Einarson; Gideon Koren
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

9.  Neonatal episodic hypoglycemia: a finding of valproic acid withdrawal.

Authors:  Dilek Çoban; Selim Kurtoğlu; Mustafa Ali Akın; Mustafa Akçakuş; Tamer Güneş
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-05-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.